It is a clinical trial to study the effect of Sharbat Habbul Aas in Vaginal discharge
Phase 3
Completed
- Conditions
- Health Condition 1: null- pathological vaginal discharge patients were enrolled
- Registration Number
- CTRI/2018/03/012553
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
inclusion criteria :
Married women
vaginal discharge with or without foul smell associated with one or two symptoms like
Low backache
Vaginal itching
Lower abdominal pain
General weakness
Pain in both legs.
Exclusion criteria:
Patients with uncontrolled systemic diseases and malignancies.
Patient with clinically detectable gross pelvic pathology
Women who have taken any medicine within two weeks before enrollment
Pregnant and lactating women
Exclusion Criteria
Patient with systemic and metabolic diseases
Clinically detectable gross pelvic pathology
Pregnant & lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaginal discharge <br/ ><br>BackacheTimepoint: 1st week, 2nd week, 3rd week, 1 month after trial
- Secondary Outcome Measures
Name Time Method vulval Itching <br/ ><br>general weakness <br/ ><br>pain in lower abdomen and both legs <br/ ><br>Timepoint: 1 week, 2nd week, 3rd week, 1 month after trial